The effect of FDG-PET on the stage distribution of non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 3, Issue 2, 2008, Pages 135-139

  Morgensztern, Daniel ^a,b   Goodgame, Boone ^a   Baggstrom, Maria Q ^a   Gao, Feng ^a   Govindan, Ramaswamy ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Division of Oncology   (United States)

Author keywords

Non small cell lung cancer; Outcomes; PET; Population; Stage distribution; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 40049103908     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181622c2c     Document Type: Article

References (20)

1. A Jemal R Siegel E Ward Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
2. R Govindan N Page D Morgensztern Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database J Clin Oncol 24 2006 4539 4544
3. DG Pfister DH Johnson CG Azzoli American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 J Clin Oncol 22 2004 330 353
4. UW Knoepp JG Ravenel CT and PET imaging in non-small cell lung cancer Crit Rev Oncol Hematol 58 2006 15 30
5. WA Fry HR Menck DP Winchester The National Cancer Data Base report on lung cancer Cancer 77 1996 1947 1955
6. WA Fry JL Phillips HR Menck Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report Cancer 86 1999 1867 1876
7. EM Toloza L Harpole DC McCrory Noninvasive staging of non-small cell lung cancer: a review of the current evidence Chest 123 2003 137S 146S
8. MK Gould WG Kuschner CE Rydzak Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis Ann Intern Med 139 2003 879 892
9. T Bury A Dowlati P Paulus Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer Eur Respir J 10 1997 2529 2534
10. RM Pieterman JW van Putten JJ Meuzelaar Preoperative staging of non-small-cell lung cancer with positron-emission tomography N Engl J Med 343 2000 254 261
11. CA Saunders JE Dussek MJ O'Doherty Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer Ann Thorac Surg 67 1999 790 797
12. CE Reed DH Harpole KE Posther Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer J Thorac Cardiovasc Surg 126 2003 1943 1951
13. H van Tinteren OS Hoekstra EF Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 2002 1388 1393
14. FV Fossella R DeVore RN Kerr Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group J Clin Oncol 18 2000 2354 2362
15. FA Shepherd J Dancey R Ramlau Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy J Clin Oncol 18 2000 2095 2103
16. FA Shepherd J Rodrigues Pereira T Ciuleanu Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 2005 123 132
17. AR Feinstein DM Sosin CK Wells The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer N Engl J Med 312 1985 1604 1608
18. J Gauger EF Patz RE Coleman Clinical stage I non-small cell lung cancer including FDG-PET imaging: sites and time to recurrence J Thorac Oncol 2 2007 499 505
19. CF Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
20. D Morgensztern B Goodgame P Chitneni Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database Survey [Abstract] J Clin Oncol 25 2007 7598